Owlstone Medical
Cystic Fibrosis Foundation Invests $2.3M in Owlstone Medical
The firm will develop an assay to detect and monitor Pseudomonas aeruginosa infection in patients with cystic fibrosis.
Owlstone Medical Raises $27M in Series E Round
The UK-based company is developing tests based on a technology that analyzes breath-based biomarkers.
The firm is nearing the launch of a liver disease test and working with the FDA to develop standards for the detection of naturally occurring compounds.
Top Five Articles on 360Dx Last Week: Roche’s New PCR Technology; Abionic Sepsis POC Test; More
Last week, readers were most interested in a story about a new respiratory test launched by Roche leveraging a new PCR technology.
Top Five Articles on 360Dx Last Week: LabCorp Ordered to Pay Ravgen Another $100M; More
Last week, readers were most interested in a story on Labcorp being ordered to pay an additional $100 million to Ravgen in a patent lawsuit.
Sep 19, 2019
Mar 21, 2019
Feb 20, 2019
Nov 7, 2018